Home
>
US Stocks
>
Autolus Therapeutics plc - ADR
Autolus Therapeutics plc - ADR
AUTL

Autolus Therapeutics plc - ADR (AUTL)

$5.615.15%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$5.73
Today Low/High
$5.47 / $5.73
52 Week Low/High
$4.6 / $16.34
Market Cap
$418.27M

Company Details

Autolus Therapeutics plcis a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
Organisation
Autolus Therapeutics plc - ADR
Headquaters
58 Wood Lane, London, United Kingdom
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Autolus Therapeutics plc - ADR (AUTL) share price today?

Can Indians buy Autolus Therapeutics plc - ADR (AUTL) shares?

How can I buy Autolus Therapeutics plc - ADR (AUTL) shares from India?

Can Fractional shares of Autolus Therapeutics plc - ADR (AUTL) be purchased?

What are the documents required to start investing in Autolus Therapeutics plc - ADR (AUTL) stocks?

We are a SEBI registered investement advisor